Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-08

Clinical Trial Update: ATV/Ritonavir Nevirapine Interaction (USPAC) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the interaction between atazanavir/ritonavir and nevirapine in HIV infection; the trial has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atazanavir/ritonavir (atazanavir/ritonavir)
  • NEVIRAPINE (nevirapine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | Phase 1 | Status: COMPLETED